249 related articles for article (PubMed ID: 30117129)
1. Non-Compartmental Pharmacokinetics and Safety of Single-Dose Eldecalcitol (ED-71) in Healthy Chinese Adult Males.
Zhao Q; Liu H; Jiang J; Wu Y; Zhong W; Li L; Miya K; Abe M; Hu P
Clin Drug Investig; 2018 Oct; 38(10):901-908. PubMed ID: 30117129
[TBL] [Abstract][Full Text] [Related]
2. An Open-Label, Randomized Pharmacokinetic Study of 2 Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu J; Fan Y; Zheng L; Wang Z; Liu Y; Shen C; Hu W
Clin Pharmacol Drug Dev; 2022 Nov; 11(11):1322-1330. PubMed ID: 35988059
[TBL] [Abstract][Full Text] [Related]
3. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
Liu X; Xue L; Zhang H; Xu Q; Zhang S; Ma S; Ding X; Liu L; Dong J; Qian L; Xia W; Jiang K; Huang C; Miao L
Clin Drug Investig; 2020 Jun; 40(6):555-566. PubMed ID: 32277364
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects.
Li T; Sun F; Liu Y; Su L; Shi P; Li X; Liu S; Wang C; Shen L; Cao Y; Wang S
Clin Pharmacol Drug Dev; 2022 Dec; 11(12):1474-1480. PubMed ID: 36018219
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, Safety Profile, and Tolerability of Tetramethylpyrazine Nitrone Tablets After Single and Multiple Ascending Doses in Healthy Chinese Volunteers.
Zhu G; Wang L; Zhong S; Han S; Peng H; Tong M; He X
Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):207-217. PubMed ID: 38381348
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
Chen R; Shen K; Chang X; Tanaka T; Li L; Hu P
Clin Ther; 2016 Aug; 38(8):1869-79. PubMed ID: 27461846
[TBL] [Abstract][Full Text] [Related]
8. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects.
Shen Q; Zhang M; Jin Y; Di X; Liu R; Wang Z
CNS Drugs; 2023 Mar; 37(3):231-242. PubMed ID: 36811740
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.
Sun L; Ding L; Wang Y; Zhou W; Yan Z; Sun W; Zhang H; Ou N; Chen X
Drugs R D; 2012 Mar; 12(1):17-28. PubMed ID: 22339483
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers.
Li Y; Li Y; Li L; Xue W; Xin K; Wang T; Shi A
Clin Drug Investig; 2023 Jun; 43(6):413-420. PubMed ID: 37269489
[TBL] [Abstract][Full Text] [Related]
12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations.
Shimizu R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R
Clin Drug Investig; 2023 Oct; 43(10):785-797. PubMed ID: 37798608
[TBL] [Abstract][Full Text] [Related]
14. A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects.
Jing S; Shiba S; Morita M; Yasuda S; Lin Y
Clin Drug Investig; 2023 Mar; 43(3):155-165. PubMed ID: 36746851
[TBL] [Abstract][Full Text] [Related]
15. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
Guo B; Wu X; Zhang Y; Shi Y; Yu J; Cao G; Zhang J
Clin Drug Investig; 2012 Jul; 32(7):475-86. PubMed ID: 22650326
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human parathyroid hormone (1-34) in healthy Chinese subjects.
Liu Y; Yang C; Li Z; Zhou J; Lv Y; Zhang Y; Zeng F; Shi S
Clin Ther; 2014 Jun; 36(6):940-52. PubMed ID: 24793535
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
[TBL] [Abstract][Full Text] [Related]
18. Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects.
Hu C; Wang Y; Song R; Yu C; Luo X; Jia J
Clin Drug Investig; 2017 Sep; 37(9):861-871. PubMed ID: 28695535
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants.
Chen K; Guan X; Yang Z; Zhou Y; Liu Z; Deng X; Liu D; Hu P; Chen R
Front Immunol; 2023; 14():1127935. PubMed ID: 37077916
[TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
